Search
Briacell Therapeutics Corp
BCTXAdd to Watchlist
3.470USD
+0.230+7.10%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
28.44MMarket Cap
LossP/E TTM
Briacell Therapeutics Corp's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Briacell Therapeutics Corp is 7.53, ranking 215 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.24, which is -14208780.02% below the recent high of 34214.50 and -42623.01% above the recent low of -102.88.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.